A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing.
Apr 16, 2021
0
171
A team of researchers at the University of Georgia College of Veterinary Medicine has developed a COVID-19 vaccine candidate that has proven successful in promoting an immune response in early test models.
Apr 21, 2020
0
135
An HIV/AIDS vaccine candidate developed by researchers at Oregon Health & Science University appears to have the ability to completely clear an AIDS-causing virus from the body. The promising vaccine candidate is being developed ...
Sep 11, 2013
1
0
As the weather cools, the number of infections of the COVID-19 pandemic are rising sharply. Hamstrung by pandemic fatigue, economic constraints and political discord, public health officials have struggled to control the ...
Nov 18, 2020
0
15
It has been a pandemic since at least biblical times, and unless effective strategies harness the global tuberculosis scourge, the disease will remain problematic and pervasive—an unending plague throughout many regions ...
Before the pandemic, the lab of Stanford University biochemist Peter S. Kim focused on developing vaccines for HIV, Ebola and pandemic influenza. But, within days of closing their campus lab space as part of COVID-19 precautions, ...
Jan 6, 2021
2
208
Researchers at the Yerkes National Primate Research Center and the Emory Vaccine Center (EVC) are first to show a new adjuvant, 3M-052, helps induce long-lasting immunity against HIV. The study results are published today ...
Jun 20, 2020
0
168
A new universal flu vaccine protects against diverse variants of both influenza A and B viruses in mice, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.
Aug 25, 2022
1
141
In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the ...
May 20, 2020
0
523
An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola ...
Apr 8, 2015
0
3926
